As of Feb 12
| +0.64 / +7.19%|
The 7 analysts offering 12-month price forecasts for Epizyme Inc have a median target of 33.00, with a high estimate of 42.00 and a low estimate of 21.00. The median estimate represents a +245.91% increase from the last price of 9.54.
The current consensus among 8 polled investment analysts is to Buy stock in Epizyme Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.